A novel, non-culture-based assay called the ribosomal RNA synthesis (RS) ratio provides a molecular metric to assess the effects of candidate tuberculosis (TB) drugs, potentially accelerating the development of treatments that can cure TB faster, researchers say.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045